表紙:逆流防止装置の世界市場:規模、シェア、COVID-19の影響分析 (2022年~2028年):MedCore
市場調査レポート
商品コード
1142647

逆流防止装置の世界市場:規模、シェア、COVID-19の影響分析 (2022年~2028年):MedCore

Anti-Reflux Devices Market Size, Share & COVID-19 Impact Analysis | Global | 2022-2028 | MedCore

出版日: | 発行: iData Research Inc. | ページ情報: 英文 19 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
逆流防止装置の世界市場:規模、シェア、COVID-19の影響分析 (2022年~2028年):MedCore
出版日: 2022年08月12日
発行: iData Research Inc.
ページ情報: 英文 19 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の逆流防止装置の市場規模は、2021年に1億1,400万米ドルとなりました。同市場は、23%の成長率で拡大し、2028年には4億8,600万米ドルに達すると予測されています。

当レポートでは、世界の逆流防止装置市場について調査し、市場の概要とともに、手技件数、市場分析と予測、市場の促進要因と抑制要因、および競合市場シェア分析などを提供しています。

目次

逆流防止装置市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場分析と予測
  • 促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 競合市場シェア分析
図表

LIST OF CHARTS

  • Chart 13-1: Anti-Reflux Device Market, Global, 2021 & 2028
  • Chart 13-2: Anti-Reflux Device Units Sold, Global, 2021
  • Chart 13-3: Anti-Reflux Device Implant Procedures by Region, Global, 2018 - 2028
  • Chart 13-4: Anti-Reflux Device Market, Global, 2018 - 2028
  • Chart 13-5: Leading Competitors, Anti-Reflux Device Market, Global, 2021

LIST OF FIGURES

  • Figure 13-1: Anti-Reflux Device Regions Covered, Global (1 of 2)
  • Figure 13-2: Anti-Reflux Device Regions Covered, Global (2 of 2)
  • Figure 13-3: Anti-Reflux Device Implant Procedures by Region, Global, 2018 - 2028
  • Figure 13-4: Anti-Reflux Device Market, Global, 2018 - 2028
  • Figure 13-5: Units Sold by Region, Anti-Reflux Device Market, Global, 2018 - 2028
  • Figure 13-6: Average Selling Price by Region, Anti-Reflux Device Market, Global, 2018 - 2028 (US$)
  • Figure 13-7: Market Value by Region, Anti-Reflux Device Market, Global, 2018 - 2028 (US$M)
  • Figure 13-8: Leading Competitors, Anti-Reflux Device Market, Global, 2021
目次
Product Code: iDATA_GLGI22_MC_AR

The total global anti-reflux device market is growing at a rate of almost 23%, which will take the 2021 market value of $114 million up to $486 million by 2028.

The full report suite on the global market for anti-reflux devices includes a variety of procedure techniques to treat GERD, such as transoral incisionless fundoplication (TIF), transesophageal radiofrequency and the LINX® technique.

MARKET REPORT DATA TYPES INCLUDED:

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2028, and Historical Data to 2018
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

PROCEDURE NUMBERS

Historically, the anti-reflux device implementation procedure market has been limited by large untreated populations and competition from medicinal treatments. However, surgeons have recently been promoting this procedure to individuals as a way to market their practice and diversify their surgical offerings. With increasing popularity, the procedure is expected to experience strong growth rates.

GLOBAL ANTI-REFLUX DEVICE MARKET TRENDS

In 202, the global market value for the anti=reflux device market decreased due to the mass cancelation of elective surgical procedures during the COVID-19 pandemic. As recovery continues throughout 2021 and 2022, strong growth should be seen over the forecast period.

GLOBAL ANTI-REFLUX DEVICE MARKET SHARE INSIGHTS

Overall, within the global anti-reflux device market there are three dominant competitors: Johnson & Johnson, EndoGastric Solutions, and Restech. In 2021, the leading competitor in the anti-reflux device market was Johnson & Johnson. Johnson & Johnson offers the LINX® reflux management system. This device is essentially a flexible band of interlinked titanium beads with magnetic cores that is wrapped around the lower part of the esophagus.

MARKET SEGMENTATION SUMMARY

  • Global Anti-Reflux Device Market

RESEARCH SCOPE SUMMARY

  • Regions - North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
  • Base Year - 2021
  • Forecast - 2022-2028
  • Historical Data - 2018-2021
  • Quantitative Coverage - Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
  • Qualitative Coverage - COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
  • Data Sources - Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE iDATA?

  • Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
  • Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
  • Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
  • Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
  • Work with us, and you'll work with seasoned professionals - vigilant of deadlines, and committed to providing the most up-to-date, accurate medical device market research.

TABLE OF CONTENT

Anti-Reflux Device Market

  • 13.1. Executive Summary
    • 13.1.1. Global Anti-Reflux Device Market Overview
    • 13.1.2. Competitive Analysis
    • 13.1.3. Regions Included
  • 13.2. Introduction
  • 13.3. Procedure Numbers
  • 13.4. Market Analysis and Forecast
  • 13.5. Drivers and Limiters
    • 13.5.1. Market Drivers
    • 13.5.2. Market Limiters
  • 13.6. Competitive Market Share Analysis